Literature DB >> 15759128

Silver staining profiles distinguish Pick bodies from neurofibrillary tangles of Alzheimer type: comparison between Gallyas and Campbell-Switzer methods.

Toshiki Uchihara1, Kuniaki Tsuchiya, Ayako Nakamura, Haruhiko Akiyama.   

Abstract

Silver staining profiles of Pick bodies (PBs) and their relation to tau-like immunoreactivity were examined on hippocampal sections and compared with those of neurofibrillary tangles of Alzheimer type (NFTs). Pairs of mirror sections were double-fluorolabeled with an anti-paired helical filament tau (AT8) antibody and thiazin red (TR), a fluorochrome that identifies fibrillary structures such as NFTs. One of the paired sections was subsequently stained using the Gallyas method (GAL), and the other using the Campbell-Switzer method (CS). By comparison of the same microscopic field on fluorolabeled sections and on both silver-stained paired sections, four different profiles of each structure could be distinguished: AT8 immunoreactivity, affinity to TR, argyrophilia with GAL or CS staining. PBs, containing mainly three-repeat (3R) tau, were positive for CS but not for GAL and its affinity to TR was, at most, weak. This selective affinity of PBs to CS is in sharp contrast with tau-positive structures of corticobasal degeneration/progressive supranuclear palsy, which are positive for GAL but not for CS, as we reported previously. This contrast is explainable if the argyrophilia with CS is related to deposits containing 3R tau, while that with GAL is linked to those containing four-repeat (4R) tau. Indeed, NFTs, containing both 3R and 4R tau, are positive for both CS and GAL, as expected. Taken together, differences in molecular composition of tau protein in these deposits are linked to their argyrophilic properties that are dependent on the staining method. Although explanations for these empirical differences are not yet available, awareness of this clear distinction is potentially of diagnostic and pathological relevance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15759128     DOI: 10.1007/s00401-005-0988-6

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  6 in total

Review 1.  Neuropathological background of phenotypical variability in frontotemporal dementia.

Authors:  Keith A Josephs; John R Hodges; Julie S Snowden; Ian R Mackenzie; Manuela Neumann; David M Mann; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2011-05-26       Impact factor: 17.088

Review 2.  Silver diagnosis in neuropathology: principles, practice and revised interpretation.

Authors:  Toshiki Uchihara
Journal:  Acta Neuropathol       Date:  2007-03-31       Impact factor: 17.088

3.  Simplification of the modified Gallyas method.

Authors:  Nobuo Kuninaka; Minato Kawaguchi; Masaru Ogawa; Ayako Sato; Kunimasa Arima; Shigeo Murayama; Yuko Saito
Journal:  Neuropathology       Date:  2014-09-01       Impact factor: 1.906

4.  Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau.

Authors:  Sayuri Taniguchi-Watanabe; Tetsuaki Arai; Fuyuki Kametani; Takashi Nonaka; Masami Masuda-Suzukake; Airi Tarutani; Shigeo Murayama; Yuko Saito; Kunimasa Arima; Mari Yoshida; Haruhiko Akiyama; Andrew Robinson; David M A Mann; Takeshi Iwatsubo; Masato Hasegawa
Journal:  Acta Neuropathol       Date:  2015-11-04       Impact factor: 17.088

5.  Silver staining (Campbell-Switzer) of neuronal α-synuclein assemblies induced by multiple system atrophy and Parkinson's disease brain extracts in transgenic mice.

Authors:  Isabelle Lavenir; Daniela Passarella; Masami Masuda-Suzukake; Annabelle Curry; Janice L Holton; Bernardino Ghetti; Michel Goedert
Journal:  Acta Neuropathol Commun       Date:  2019-09-16       Impact factor: 7.801

Review 6.  Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research.

Authors:  Christina M Moloney; Val J Lowe; Melissa E Murray
Journal:  Alzheimers Dement       Date:  2021-04-02       Impact factor: 21.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.